General information about company |
|||
|---|---|---|---|
| Scrip Code | 539551 | ||
| NSE Symbol | NH | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE410P01011 | ||
| Name of company | NARAYANA HRUDAYALAYA LTD. | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2025 | ||
| Date of end of financial year | 31-Mar-2026 | ||
| Date of board meeting when results were approved | 01-Aug-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 28-Jul-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | First quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Unaudited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |||
| Segment Reporting | Multi segment | ||
| Description of single segment | |||
| Start date and time of board meeting | 01-Aug-2025 15:30:00 | ||
| End date and time of board meeting | 01-Aug-2025 18:40:00 | ||
| Whether cash flow statement is applicable on company | |||
| Type of cash flow statement | |||
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Apr-2025 | |
| B | Date of end of reporting period | 30-Jun-2025 | |
| C | Whether results are audited or unaudited | Unaudited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 15072690000 | ||
| Other income | 237920000 | ||
| Total income | 15310610000 | ||
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0 | |
| (b) | Purchases of stock-in-trade | 3053990000 | |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 4110000 | |
| (d) | Employee benefit expense | 2955230000 | |
| (e) | Finance costs | 451630000 | |
| (f) | Depreciation, depletion and amortisation expense | 843020000 | |
| (f) | Other Expenses | ||
| 1 | Professional fees to doctors | 2441780000 | 2441780000 |
| 2 | Other Expenses | 3248070000 | 3248070000 |
| Total other expenses | 5689850000 | ||
| Total expenses | 12997830000 | ||
| 3 | Total profit before exceptional items and tax | 2312780000 | |
| 4 | Exceptional items | 0 | |
| 5 | Total profit before tax | 2312780000 | |
| 6 | Tax expense | ||
| 7 | Current tax | 341650000 | |
| 8 | Deferred tax | 6210000 | |
| 9 | Total tax expenses | 347860000 | |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | -4410000 | |
| 11 | Net Profit Loss for the period from continuing operations | 1960510000 | |
| 12 | Profit (loss) from discontinued operations before tax | 7250000 | |
| 13 | Tax expense of discontinued operations | 690000 | |
| 14 | Net profit (loss) from discontinued operation after tax | 6560000 | |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | |
| 16 | Total profit (loss) for period | 1967070000 | |
| 17 | Other comprehensive income net of taxes | 4560000 | |
| 18 | Total Comprehensive Income for the period | 1971630000 | |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 1966510000 | ||
| Total profit or loss, attributable to non-controlling interests | 560000 | ||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 1971050000 | ||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 580000 | ||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 2043610000 | ||
| Face value of equity share capital | 10 | ||
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 9.65 | ||
| Diluted earnings (loss) per share from continuing operations | 9.65 | ||
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0.03 | ||
| Diluted earnings (loss) per share from discontinued operations | 0.03 | ||
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 9.68 | ||
| Diluted earnings (loss) per share from continuing and discontinued operations | 9.68 | ||
| 24 | Debt equity ratio | 0.0058 | |
| 25 | Debt service coverage ratio | 0.0241 | |
| 26 | Interest service coverage ratio | 0.0611 | |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
Disclosure of notes on financial results |
|||
|---|---|---|---|
| Textual Information(1) | Rs. (4.41) million disclosed in Point No. 10, Part 1, represents the share of loss from equity-accounted investees. | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Apr-2025 | ||||||
| Date of end of reporting period | 30-Jun-2025 | ||||||
| Whether accounts are audited or unaudited | Unaudited | ||||||
| Nature of report standalone or consolidated | Consolidated | ||||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Medical and healthcare related services | 15070620000 | 15070620000 | ||||
| 2 | Others | 458580000 | 458580000 | ||||
| 3 | Unallocated other income | 239340000 | 239340000 | ||||
| Total Segment Revenue | 15768540000 | ||||||
| Less: Inter segment revenue | 97150000 | 97150000 | |||||
| Revenue from operations | 15671390000 | ||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Medical and healthcare related services | 2768370000 | 2768370000 | ||||
| 2 | Others | -240460000 | -240460000 | ||||
| 3 | Unallocated other income | 239340000 | 239340000 | ||||
| Total Profit before tax | 2767250000 | ||||||
| i. Finance cost | 451630000 | 451630000 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 0 | 0 | |||||
| Profit before tax | 2315620000 | ||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Medical and healthcare related services | 58783920000 | 58783920000 | ||||
| 2 | Others | 1600920000 | 1600920000 | ||||
| 3 | Unallocated other income | 0 | 0 | ||||
| Total Segment Asset | 60384840000 | 60384840000 | |||||
| Un-allocable Assets | 13446360000 | 13446360000 | |||||
| Net Segment Asset | 73831200000 | 73831200000 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Medical and healthcare related services | 14002420000 | 14002420000 | ||||
| 2 | Others | 477460000 | 477460000 | ||||
| 3 | Unallocated other income | 0 | 0 | ||||
| Total Segment Liabilities | 14479880000 | 14479880000 | |||||
| Un-allocable Liabilities | 21097340000 | 21097340000 | |||||
| Net Segment Liabilities | 35577220000 | 35577220000 | |||||
| Disclosure of notes on segments | |||||||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Apr-2025 | |
| B | Date of end of reporting period | 30-Jun-2025 | |
| C | Whether results are audited or unaudited | Unaudited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Re-measurement gains/ (losses) on defined benefit plans | -11420000 | -11420000 |
| 2 | Equity instruments through other comprehensive income, net | 20530000 | 20530000 |
| Total Amount of items that will not be reclassified to profit and loss | 9110000 | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -2130000 | |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Effective portion of gains/ (losses) in cash flow hedges | 1730000 | 1730000 |
| 2 | Effective portion of gains/ (losses) of net investment hedge in a foreign operation | -290000 | -290000 |
| 3 | Exchange differences in translating the financial statement of foreign operations | -7680000 | -7680000 |
| Total Amount of items that will be reclassified to profit and loss | -6240000 | ||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 440000 | |
| 5 | Total Other comprehensive income | 4560000 | |